Co-Authors
This is a "connection" page, showing publications co-authored by GEORGE CHOLANKERIL and JENNIFER KRAMER.
Connection Strength
0.631
-
Reply to: "Transitioning FIB-4 score: From fibrosis screening tool to key biomarker for clinical endpoints". J Hepatol. 2024 Nov; 81(5):e230-e231.
Score: 0.243
-
Longitudinal changes in fibrosis markers are associated with risk of cirrhosis and hepatocellular carcinoma in non-alcoholic fatty liver disease. J Hepatol. 2023 03; 78(3):493-500.
Score: 0.216
-
GLP-1 Receptor Agonists and Risk for Cirrhosis and Related Complications in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease. JAMA Intern Med. 2024 Nov 01; 184(11):1314-1323.
Score: 0.062
-
Cost of Care for Patients With Cirrhosis. Am J Gastroenterol. 2024 03 01; 119(3):497-504.
Score: 0.057
-
Clinical Course and Outcomes of Patients with Nonalcoholic Fatty Liver Disease-Related Hepatocellular Cancer (NAFLD-HCC). Dig Dis Sci. 2023 03; 68(3):1060-1070.
Score: 0.053